Closed pleural biopsy in the diagnostics of malignant pleural involvement

Česká verzia

Authors: Petr Jakubec ¹; Vítězslav Kolek ¹; Aleš Václavík ¹; Jaromír Zatloukal ¹; Stanislav Losse ¹; Ladislava Kučerová ²; Tomáš Tichý ²; Kateřina Musilová ²
Authors place of work: Klinika plicních nemocí a tuberkulózy LF UP a FN Olomouc, přednosta prof. MUDr. Vítězslav Kolek, DrSc. ¹; Ústav klinické a molekulární patologie LF UP a FN Olomouc, přednosta prof. MUDr. Zdeněk Kolář, CSc. ²
Published in the journal: Vnitř Lék 2014; 60(5-6): 423-430
Category: Original Contributions

Summary

Introduction:
Pleural effusion is a frequent reason for a pulmonologist´s investigation. The cornerstone is to distinguish transudative pleural effusion from exudative pleural effusion. In the case of the exudative pleural effusion the next step is detection of malignant etiology of pleural effusion. We have a variety of any non-invasive or invasive examinations. The pleural biopsy is one of the most important methods for diagnostics of malignant pleural effusion.

Material and methods:
Two hundred and twenty-two closed pleural biopsies (CPB) were performed in 208 patients with pleural effusion, where the cytologic examination of pleural fluid was negative. The authors evaluated the value of CPB for the diagnosis of malignant pleural involvement.

Results and conclusion:
Total sensitivity, specificity, accuracy, positive predictive value and negative predictive value were 63.1 %, 100 %, 73.9 %, 100 % and 52.8 %, but in the group of mesotheliomas these results were 59.1 %, 100 %, 79.4 %, 100 % and 70.7 %. The incidence of complications and representative sampling of the pleura was mentioned. The authors compared the diagnostic value and the incidence of complications of various diagnostic methods in malignant pleural involvement by data in the literature.

Key words:
closed pleural biopsy – diagnostic methods – histological diagnosis – malignant pleural involvement – pleural effusion

Zdroje

1. Light RW. Pleural disease. 2nd ed. Lea and Febiger: Philadelphia 1990. ISBN 0812113187.

2. Du Rand I, Maskell N. Introduction and methods: British Thoracic Society pleural disease guideline. Thorax 2010; 65: (Suppl 2): ii1-ii3.

3. Marel M, Fila L. Novinky v péči o nemocné s pleurálními výpotky. Postgrad Med 2011; 13(6): 656–661.

4. Rubins J. Pleural effusion. eMedicine 2013. Dostupné z: <http://emedicine.medscape.com/article/299959-overview>.

5. Sahn SA. The value of pleural fluid analysis. Am J Med Sci 2008; 335(1): 7–15.

6. Esme H, Calik M. Management of Malignant Pleural Effusion. In: Firstenberg MS (Ed). Principles and Practice of Cardiothoracic Surgery. InTech 2013: 85–108. ISBN 978–953–51–1156–6. Dostupné z WWW: <http://www.intechopen.com/books/principles-and-practice-of-cardiothoracic-surgery/management-of-malignant-pleural-effusion>.

7. Light RW, MacGregor MI, Luchsinger PC et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77(4): 507–513.

8. Heffner JE, Brown LK, Barbieri CA. Diagnostic value of tests that discriminate between exudative and transudative pleural effussions. Primary Study Investigators. Chest 1997; 111(4): 970–980.

9. Porcel JM, Vives M, Vicente de Vera MC et al. Useful tests on pleural fluid that distinguish transudates from exudates. Ann Clin Biochem 2001; 38(Pt 6): 671–675.

10. Roth BJ, O´Meara TF, Cragun WH. The serum-effusion albumin gradient in the evaluation of pleural effusions. Chest 1990; 98(3): 546–549.

11. Ansari T, Idell S. Management of undiagnosed persistent pleural suffusions. Clin Chest Med 1998; 19(2): 407–417.

12. Romero-Candeira S, Fernández C, Martín C et al. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med 2001; 110(9): 681–686.

13. Romero-Candeira S, Hernandéz L The separation of transudates and exsudates with particular reference to the protein gradient. Curr Opin Pulm Med 2004; 10(4): 294–298.

14. Marel M, Zrůstová M, Stasný B et al. Incidence of pleural effusions in well-defined region: epidemiologic study in Central Bohemia. Chest 1993; 104(5): 1486–1489.

15. Light RW. Clinical practice. Pleural effusion. N Engl J Med 2002; 346(25): 1971–1977.

16. Marel M et al. Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990. Chest 1995; 107(6): 1598–1603.

17. Marel M, Fila L Diferenciální diagnostika a léčba maligních pleurálních výpotků. Klin Onkol 2001; 14(zvl č): 16–19.

18. Rahman NM, Chapman SJ, Davies RJO. Pleural effusion: a structured approach to care. Br Med Bull 2005; 72: 31–47.

19. DiBonito L, Falconieri G, Colautti I et al. The positive pleural effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation. Acta Cytol 1992; 36(3): 329–332.

20. Johnston WW. The malignant pleural effusion. A review of cytopathologic diagnoses of 584specimens from 472 consecutive patients. Cancer 1985; 56(4): 905–909.

21. Hsu C. Cytologic detection of malignancy in pleural effusion: a review of 5255 samples from 3811 patients. Diagn Cytopathol 1987; 3(1): 8–12.

22. Antunes G, Neville E, Duffy J et al. BTS guidelines for the management of malignant pleural effusions. Thorax 2003; 58(Suppl 2): ii29–38.

23. Molengraft van de FJ, Vooijs GP. Survival of patiens with malignancy-associated effusions. Acta Cytol 1989; 33(6): 911–916.

24. Bonnefoi H, Smith IE. How should cancer presenting as a malignant effusion be managed? Br J Cancer 1996; 74(5): 832–835.

25. Engel G. Diagnostický postup při pleurálním výpotku. Vnitř Lék 2000; 46(2): 126–129.

26. Korczynski P, Krenke R, Safianowska A et al. Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions. Eur J Med Res 2009; 14: (Suppl 4): S128-S133.

27. Li CS, Cheng BC, Ge W et al. Clinical value of CYFRA 21–1, NSE, CA 15–3, CA 19–9 and CA 125 assay in the elderly patients with pleural effusions. Int J Clin Pract 2007; 61(3): 444–448.

28. van den Heuvel MM, Korse CM, Bonfrer JMG et al. Non-invasive diagnosis of pleural malignancies: the role of tumour markers. Lung Cancer 2008; 59(3): 350–354.

29. Shitrit D, Zingerman B, Shitrit AB et al. Diagnostic Value of CYFRA 21–1, CEA, CA 19–9, CA 15–3 and CA 125 Assays in Pleural Effusions: Analysis of 116 Cases and Review if the Literature. Oncologist 2005; 10(7): 501–507.

30. Porcel JM, Vives M, Esquerda A et al. Use of a panel of tumor markers (carcinoembryonic antigen, cancor antigen 125, carbohydrate antigen 15–3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004; 126(6): 1757–1763.

31. Ferrer F, Villarino MA, Encabo G et al. Diagnostic utility of CYFRA 21–1, carcinomembryonic antigen, CA 125, neurol specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Cancer 1999; 86(8): 1488–1495.

32. Scherpereel A, Grigoriu B, Conti M et al. Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma. Am J Respir Crit Care Med 2006; 173(10): 1155–1160.

33. Pass HI, Wali A, Tang N et al. Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions. Ann Thorac Surg 2008; 85(1): 265–272.

34. Davies HE, Sadler RS, Bielsa S et al. Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions. Am J Respir Crit Care Med 2009; 180(5): 437–444.

35. Fujimoto N, Gemba K, Asano M et al. Soluble mesothelin-related protein in pleural effusion from patients with malignant pleural mesothelioma. Experimental and Therapeutic Medicine 2010; 1(2): 313–317.

36. Fenton KN, Richardson JD. Diagnosis and management of malignant pleural effusions. Am J Surg 1995; 170(1): 69–74.

37. Bueno CE, Clemente MG, Astro BC et al. Cytologic and bacteriologic analysis of fluid and pleural biopsy specimens with Cope´s needle: study of 414 patients. Arch Intern Med 1990; 150(6): 1190–1194.

38. Maskell NA, Butland RJ. BTS guidelineas for the investigation of a unilateral pleural effusion in adults. Thorax 2003; 58(Suppl 2): ii8-ii17.

39. Hooper C, Lee YCG, Maskell N. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65(Suppl 2): ii4-ii17.

40. Garcia L, Ducatman BS, Wang HH. The value of multiple fluid specimen in the cytological diagnosis of malignancy. Mod Pathol 1994; 7(6): 665–668.

41. Scherpereel A, Astoul P, Baas P et al. European Respiratory Society/European Society of Thoracic Surgeons Task Force. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010; 35(3): 479–495.

42. Husain AN, Colby T, Ordonez N et al (International Mesothelioma Interest Group). Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2013; 137(5): 647–667.

43. Cagle PT, Allen TC. Pathology of the pleura: what the pulmonologists need to know. Respirology 2011; 16(3): 430–438.

44. Chakrabarti B, Ryland I, Sheard J et al. The role of Abrams percutaneous pleural biopsy in the investigation of exudative pleural effusions. Chest 2006; 129(6): 1549–1555.

45. Sriram K, Jersmann H. Pneumothorax, pneumomediastinum and subcutaneous emphysema following closed percutaneous pleural biopsy: a case report. Cases J 2008; 1(1): 274.

46. Baumann MH. Closed pleural biopsy: not dead yet! Chest 2006; 129(6): 1398–1400.

47. Nance KV, Shermer RW, Askin FB. Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination. Mod Pathol 1991; 4(3): 320–324.

48. Salyer WR, Eggleston JC, Erozan YS. Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. Chest 1975; 67(5): 536–539.

49. Prakash UB, Reiman HM. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1985; 60(3): 158–164.

50. Poe RH, Israel RH, Utell MJ et al. Sensitivity, specificity and predictive values of closed pleural biopsy. Arch Intern Med 1984; 144(2): 325–328.

51. Maskell NA, Gleeson FV, Davies RJO. Standard pleural biopsy vs CT-guided cutting needle biopsy for diagnosis of malignant disease in pleural effusions: a randomized controlled trial. Lancet 2003; 361(9366): 1326–1331.

52. Bhattacharya S, Bairagya TD, Das A et al. Closed pleural biopsy is still useful in the evaluation of malignant pleural effusion. J Lab Physicians 2012; 4(1): 35–38.

53. Pandit S, Chaudhuri AD, Datta SB et al. Role of pleural biopsy in etiological diagnosis of pleural effusion. Lung India 2010; 27(4): 202–204.

54. Ruffie P, Feld R, Minkin S et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 1989; 7(8): 1157–1168.

55. Boutin C, Rey F. Thoracoscopy in malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer 1993; 72(2): 389–404.

56. Achatzy R, Beba W, Ritschler R et al. The diagnosis, therapy and prognosis of diffuse malignant mesothelioma. Eur J Cardiothorac Surg 1989; 3(5): 445–447.

57. Attanoos RL, Gibbs AR. The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma. Histopathology 2008; 53(3): 340–344.

58. McLaughlin KM, Kerr KM, Currie GP. Closed pleural biopsy to diagnose mesothelioma: dead or alive? Lung Cancer 2009; 65(3): 388–389.

59. Gopi A, Madhavan SM, Sharma SK et al. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 2007; 131(3): 880–889.

60. Hira HS, Ranjan R. Role of percutaneous closed needle pleural biopsy among patients of undiagnosed exudative pleural effusion. Lung India 2011; 28(2): 101–104.

61. Diacon AH, Van de Wal BW, Wyser C et al. Diagnostic tools in tuberculous pleurisy: a direct comparative study. Eur Respir J 2003; 22(4): 589–591.

62. Chang DB, Yang PC, Luh KT et al. Ultrasound-guided pleural biopsy with Tru-cut needle. Chest 1991; 100(5): 1328–1333.

63. Koegelenberg CF, Diacon AH. Pleural controversy: close needle pleural biopsy or thoracoscopy – which first? Respirology 2011; 16(5): 738–746.

64. Diacon AH, Schuurmans MM, Theron J et al. Safety and yield of ultrasound-assisted transthoracic biopsy performed by pulmonologists. Respiration 2004; 71(5): 519–522.

65. Scott EM, Marshall TJ, Flower CD et al. Diffuse pleural thickening: percutaneous CT-guided cutting needle biopsy. Radiology 1995; 194(3): 867–870.

66. Adams RF, Gleeson FV. Percutaneous image-guided cutting needle biopsy of the pleura in the presence of a suspected malignant effusion. Radiology 2001; 219(2): 510–514.

67. Adams RF, Gray W, Davies RJO et al. Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma. Chest 2001; 120(6): 1798–1802.

68. Metintas M, Ak G, Dundar E et al. Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial. Chest 2010; 137(6): 1362–1368.

69. Aksoy E, Atac G, Sevim T et al. Diagnostic yield of closed pleural brushing. Tuberk Toraks 2005; 53(3): 238–244.

70. Davies HE, Rosenstengel A, Gary Lee YC. The diminishing role of surgery in pleural disease. Curr Opin Pulm Med 2011; 17(4): 247–254.

71. Thangakunam B, Devasahayam JC, Prince J et al. Semi-rigid thoracoscopy: initial experience from a tertiary care hospital. Indian J Chest Dis Allied Sci 2010; 52(1): 25–27.

72. Lee P, Hsu A, Lo C et al. Prospective evaluation of flex-rigid pleuroscopy for indeterminate pleural effusion: Accuracy, safety and outcome. Respirology 2007; 12(6): 881–886.

73. Prabhu VG, Narasimhan R. The role of pleuroscopy in undiagnosed exudative pleural effusion. Lung India 2012; 29(2): 128–130.

74. Medford ARL, Awan YM, Marchbank A et al. Diagnostic and therapeutic performance of video-assisted thoracoscopic surgery (VATS) in Investigation and management of pleural exudates. Ann R Coll Surg Engl 2008; 90(7): 597–600.

75. Haberal MA, Tülüce K, Köksal E et al. Videothoracoscopy in pleural effusions: A review of 41 cases. J Exp Clin Med 2013; 30(1): 35–37.

76. Menzies R, Charbonneau M. Thoracoscopy for the diagnosis of pleural disease. Ann Intern Med 1991; 114(4): 271–276.

77. Boutin C, Astoul P, Seitz B. The role of thoracoscopy in the evaluation and management of pleural effusions. Lung 1990; 168(Suppl): S1113-S1121.

78. Harris RJ, Kavuru MS, Mehta AC et al. The impact of thoracoscopy on the management of pleural disease. Chest 1995; 107(3): 845–852.

79. Loddenkemper R. Thoracoscopy – state of the art. Eur Respir J 1998; 11(1): 213–221.

80. Blanc FX, Atassi K, Bignon J et al. Diagnostic value of medical thoracoscopy in pleural disease: a 6-year retrospective study. Chest 2002; 121(5): 1677–1683.

81. Screaton NJ, Flower CD. Percutaneous needle biopsy of the pleura. Radiol Clin North Am 2000; 38(2): 293–301.